尿中より検出したEnterobacteriaceae4菌種に対するMecillinamの抗菌力に関する検討 (Pivmecillinamによる尿路感染症の治療<特集>)
スポンサーリンク
概要
- 論文の詳細を見る
In vitro antibacterial activity of Mecillinam was studied against clinical isolates of E. coli, K. pneumoniae, E.cloacae and C.freundii in comparison with ST (combination of sulfamethoxazole and trimethoprim) and PPA (pipemidic acid). In case of E. coli and K. pneumoniae, both of which are often isolated from urine, mecillinam showed stronger antibacterial activity than ST and PPA, while, in case of E. cloacae, there was no big difference between 3 compounds and, in case of C.freundii, PPA seems to have stronger activity than mecillinam. As it will be suspected that the resistant strains will increase in future, the change of clinical isolates, trend of the use of antibiotics as well as the antibacterial activity against other bacteria than 4 kinds mentioned above should be constantly checked.
- 泌尿器科紀要刊行会の論文
泌尿器科紀要刊行会 | 論文
- MVAC療法後の転移性尿路上皮癌に対するGemcitabine, Docetaxel, Carboplatin併用化学療法の検討
- Grade 3 Ta-1表在性膀胱癌に対する膀胱温存治療
- 腹腔鏡下に摘出した後腹膜神経線維腫の1例
- 移植腎生検による腎内動脈瘤破裂の1例
- Modified M-VAC療法後に残存腫瘍切除を施行した進行尿路上皮癌患者の治療成績